By immunohistochemical analyses of the ventral rat prostate, we previously observed an increase in the TGF-β signaling molecules Smad2, Smad3 and Smad4 in association with apoptosis induced by castration, together with increased immunoreactivity for phosphorylated and activated Smad2 [2] . In parallel, there was an increase in the immunoreactivity for Smad7, which was present in epithelial cells showing characteristic signs of apoptotic nuclei, in the form of condensed and fragmented nuclei [2, 3] . The finding that Smad7 is expressed in prostatic epithelial cells undergoing apoptosis [2] led us to investigate whether Smad7 is important in the regulation of TGF-β1-induced apoptosis in PC-3U cells. Consistent with previous observations in mink lung cells, human thyroid carcinoma cells and glioma cells [1] , we observed a rapid increase in Smad7 mRNA expression after TGF-β1 stimulation of PC-3U cells, reaching a peak level after 1.5 hours (Figure 1a) . We also observed an increased level of Smad7 protein after 6-24 hours of TGF-β1 challenge (Figure 1b) . The protein levels of Smad7 remained high 48 hours after TGF-β1 stimulation, but decreased after 72 hours (data not shown). Stimulation of PC-3U cells by 10 ng/ml TGF-β1 in medium containing 1% fetal bovine serum (FBS) for 24 hours, 48 hours and 72 hours led to an increased number of apoptotic cells compared with unstimulated control cells, as shown by a DNA-fragmentation assay (Figure 1c) . Thus, TGF-β1 induces Smad7 expression, which precedes the induction of apoptosis in PC-3U cells.
To investigate the effects of Smad7, FLAG-tagged Smad7 (F-Smad7) was stably transfected into PC-3U cells under the control of an inducible metallothionein promoter (pMEP4). Several different subclones were isolated; two of the clones (clones C and I; see Supplementary material) showed high expression of F-Smad7 measured after 12 hours of treatment with CdCl 2 (optimum concentration 0.5-1.0 µM; data not shown). A low amount of F-Smad7 was seen also in the absence of CdCl 2 , owing to the leakiness of the metallothionein promoter. The expression of F-Smad7 was not affected by TGF-β1 stimulation (see Supplementary material). No induction of Smad7 mRNA was seen in untransfected control cells after stimulation with CdCl 2 at the different time points investigated. Ectopic expression of F-Smad7 inhibited TGF-β-mediated upregulation of plasminogen activator inhibitor 1 (PAI-1) and growth inhibition (see Supplementary material); therefore, the expressed F-Smad7 was functionally active [1, 4, 5] .
To investigate the effects of Smad7 expression on apoptosis, several different assays were used. DNA was isolated from confluent, CdCl 2 -treated cultures of F-Smad7-expressing clone I and mock-transfected PC-3U cells and analyzed by electrophoresis in an agarose gel. As seen in Figure 2a , TGF-β1-induced DNA fragmentation was observed in the mock-transfected control cells. However, To explore whether Smad7 expression is necessary for TGF-β1-induced apoptosis, we attempted to block Smad7 expression by an antisense approach. The Smad7 cDNA was cloned in the reverse orientation downstream of a cytomegalovirus promoter and stably transfected into PC-3U cells. Northern blot analysis revealed high expression of the antisense Smad7 mRNA (Figure 3a) . Western blot analysis showed that the TGF-β-induced increase in Smad7 protein was attenuated in cells transfected with antisense Smad7 (AS-S7) compared with control cells (Figure 3b) . Importantly, AS-S7 cells stimulated with TGF-β1 for 24-48 hours showed lower numbers of apoptotic cells than control cells, as analyzed by DNA fragmentation (Figure 3c ), TUNEL or Mitosensor analysis (data not shown). Endogenous Smad7 was predominantly localized in the nucleus of the PC-3U cells (control and AS-S7 cells), as analyzed by immunofluorescence. After TGF-β1 stimulation, a fraction of Smad7 was also close to the cell membrane, as reported previously [5] . There were, therefore, no obvious differences in the subcellular localisation of endogenous Smad7 between AS-S7 PC-3U cells and control cells, except that the intensity of immunofluorescence was lower (data not shown).
We next transfected synthetic sense and antisense Smad7 phosphorothioate-modified oligonucleotides into PC-3U cells to confirm that Smad7 can act as a mediator of TGF-β1-induced apoptosis. Treatment with TGF-β1 for 24-48 hours induced apoptosis in control cells transfected with sense Smad7 oligonucleotides and untreated PC-3U cells (data not shown), whereas antisense Smad7 oligonucleotides prevented apoptosis, as shown by Mitosensor analysis (Figure 3d) . Similar results were obtained with the human prostatic carcinoma cell line DU 145 and the human keratinocyte cell line HaCaT, as shown by 4′-6 diamidino-2-phenylindoledihydrochloride (DAPI) staining, which allows identification and quantification of apoptotic nuclei (Table 1 and Supplementary material) and by Mitosensor analysis (data not shown).
In this study we provide evidence that TGF-β1-induced apoptosis in human prostatic carcinoma cells is mediated by Smad7; overexpression of Smad7 potently induces apoptosis, and expression of antisense Smad7 mRNA or antisense oligonucleotides for Smad7 prevents TGF-β1-induced apoptosis. Further studies are needed to investigate the mechanisms by which Smad7 overexpression results in apoptosis. By contrast, in hematopoietic cells, Smad7 inhibits TGF-β-induced apoptosis [6, 7] ; there could, therefore, be cell-type differences in the proapoptotic effect of Smad7. Expression of Smad7 is regulated by several different stimuli, including the TGF-β family members TGF-β,
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Figure 3
Antisense Smad7 prevents TGF-β1-induced apoptosis. (a) Northern blot analysis of Smad7 mRNA in control cells and in the stably transfected antisense Smad7 clone (AS-S7). Ectopically expressed antisense Smad7 (AS-Smad7) is indicated. The blot was reprobed for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading control. (b) Western blot analysis using an anti-Smad7 antiserum of cell lysates prepared from control PC-3U cells and AS-S7 cells, stimulated with 10 ng/ml TGF-β1 for 12 h. (c) Analysis of fragmentation of DNA isolated from control PC-3U cells and AS-S7 cells, treated or not with TGF-β1 (10 ng/ml) for 24 h and 48 h, by electrophoresis in a 1.8% agarose gel, staining with ethidium bromide and illumination with UV light. (d) Analysis of apoptosis of PC-3U cells treated with or without TGF-β1 and/or synthetic antisense Smad7 oligonucleotides for 36 h, by immunofluorescence with Mitosensor (Clontech). The cationic dye is taken up in normal mitochondria (yellow-red), whereas in early apoptotic cells this uptake does not occur (green) [10] . Phosphorothioate single-stranded oligonucleotides matching region 107-128 (5′-GCTGCGGGGAGAAGGGGCGAC-3′) of the human Smad7 complementary DNA sequence (GenBank accession number AF010193) were synthesized in the sense and antisense orientations and used as described by Ulloa et al. [8] . 
Materials and methods
Cell culture
The human prostatic carcinoma cell lines PC-3U, a subline originating from PC-3 cells [4] , and DU 145 were routinely grown in RPMI 1640 with 10% FBS. HaCaT cells were grown in DMEM with 10% FBS. In all assays, TGF-β1 treatment was applied at 10 ng/ml in medium containing 1% FBS.
Stable transfections, metabolic labeling, thymidine incorporation assay and immunoprecipitation
Stable transfection of PC-3U cells with pMEP4-Smad7 expression vector or pRKV5 Smad7 antisense expression vector, metabolic labeling of cells, immunoprecipitation and thymidine incorporation assay were performed as described previously [5] . Antisense-Smad7-expressing clones were selected with 0.2 mg/ml gentamicin (GibcoBRL, Life Technologies). Cells transfected with pMEP4-Smad7 were stimulated with 0.5 µM or 1.0 µM CdCl 2 for 12-24 h to induce expression of F-Smad7.
Western blot analysis
For detection of endogenous Smad7, KAF antisera were used [2] ; lysates from COS-7 cells transiently transfected with F-Smad7, were used as a positive control in immunoblotting. The immunoreactivity was blocked by the peptide used for immunization, demonstrating specificity (data not shown).
Supplementary material
Figures showing characterization of the stably transfected F-Smad7 clones, thymidine incorporation assay, the caspase dependency of F-Smad7-induced apoptosis and the importance of Smad7 in TGF-β1-induced apoptosis in DU 145 and HaCaT cells are available at http://current-biology.com/supmat/supmatin.htm.
